Körtvélyessy P, Breu M, Pawlitzki M, Metz I, Heinze HJ, Matzke M, Mawrin C, Rommer P, Kovacs GG, Mitter C, Reindl M, Brück W, Wandinger KP, Lassmann H, Höftberger R, Leypoldt F: ADEM-like presentation, anti-MOG antibodies, and MS pathology: TWO case reports. Neurol Neuroimmunol Neuroinflamm 2017; 4: e335. doi: 10.1212/NXI.0000000000000335. eCollection 2017 May.
Miske R, Gross CC, Scharf M, Golombeck KS, Hartwig M, Bhatia U, Schulte-Mecklenbeck A, Bönte K, Strippel C, Schöls L, Synofzik M, Lohmann H, Dettman IM, Deppe M, Mindorf S, Warnecke T, Denno Y, Teegen B, Probst C, Brakopp S, Wandinger KP, Wiendl H, Stöcker W, Meuth SG, Komorowski L, Melzer N: Neurochondrin is a neuronal target antigen in autoimmune cerebellar degeneration. Neurol Neuroimmunol Neuroinflamm 2017; 4: e307.
Finke C, Prüss H, Heine J, Reuter S, Kopp UA, Wegner F, Then Bergh F, Koch S, Jansen O, Münte, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T: Evaluation of Cognitive Deficits and Structural Hippocampal Damage in Encephalitis with Leicine. Rich, Glioma-Inactivated 1 Antibodies. JAMA Neurol 2017; 74: 50-9.
Juhl D, Nowak-Göttl U, Blümel J, Görg S, Hennig H: Lack of evidence for the transmission of hepatitis E virus by coagulation factor concentrates based on seroprevalence data. Transfus Med 2017; doi: 10.1111/tme.12498. Epub 2017 Dec 27.
Nowak-Göttl U, Dietrich K, Kruempel A, Geisen C, Mitchell LG: The VKORC1 and CYP2C9 genotypes significantly effect Vitamin K antagonist dosing only in patients over the age of 20years. Blood Cells Mol Dis 2017; 67: 54-8.
Kenet G, Nowak-Göttl U: Editorial for special pediatric hemostasis issue BCMD. Blood Cells Mol Dis. 2017; 67: 1.
Boeckelmann D, Hengartner H, Greinacher A, Nowak-Göttl U, Sachs UJ, Peter K, Sandrock-Lang K, Zieger B: Patients with Bernard-Soulier syndrome and different severity of the bleeding phenotype. Blood Cells Mol Dis 2017; 67: 69-74.
Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D: Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13.
Strauss T, Elisha N, Ravid B, Rosenberg N, Lubetsky A, Levy-Mendelovich S, Morag I, Nowak-Göttl U, Kenet G: Activity of Von Willebrand factor and levels of VWF-cleaving protease (ADAMTS13) in preterm and full term neonates. Blood Cells Mol Dis 2017; 67: 14-7.
Kenet G, Limperger V, Shneyder M, Nowak-Göttl U: Risk factors for symptomatic venous and arterial thromboembolism in newborns, children and adolescents - What did we learn within the last 20 years? Blood Cells Mol Dis 2017; 67: 18-22.
Nowak-Göttl U, Clausnizer H, Kowalski D, Limperger V, Krümpel A, Shneyder M, Reinke S, Rocke A, Juhl D, Steppat D, Krause M: Health-related quality of life in children, adolescents and adults with hereditary and acquired bleeding disorders. Blood Cells Mol Dis 2017; 67: 96-101.
Nowak-Göttl U, Limperger V, Kenet G, Degenhardt F, Arlt R, Domschikowski J, Clausnizer H, Liebsch J, Junker R, Steppat D: Developmental hemostasis: A lifespan from neonates and pregnancy to the young and elderly adult in a European white population. Blood Cells Mol Dis 2017; 67: 2-13.
van Ommen CH, Nowak-Göttl U: Inherited Thrombophilia in Pediatric Venous Thromboembolic Disease: Why and Who to Test. Front Pediatr 2017; 5: 50.
Sultan S, Dowling M, Kirton A, DeVeber G, Linds A, Elkind MSV; IPSS Investigators: Dyslipidemia in Children With Arterial Ischemic Stroke: Prevalence and Risk Factors. Pediatr Neurol 2018; 78: 46-54.
Haussleiter IS, Wandinger KP, Juckel G: A case of GABAR antibodies in schizophrenia. BMC Psychiatry 2017; 17: 9.
Malviya M, Barman S, Golombeck KS, Planagumà J, Mannara F, Strutz-Seebohm N, Wrzos C, Demir F, Baksmeier C, Steckel J, Falk KK, Gross CC, Kovac S, Bönte K, Johnen A, Wandinger KP, Martín-García E, Becker AJ, Elger CE, Klöcker N, Wiendl H, Meuth SG, Hartung HP, Seebohm G, Leypoldt F, Maldonado R, Stadelmann C, Dalmau J, Melzer N, Goebels N: NMDAR encephalitis: passive transfer from man to mouse by a recombinant antibody. Ann Clin Trans Neurol 2017; 4: 768-83.
Obermayr E, Bednarz-Knoll N, Orsetti B, Weier HU, Lambrechts S, Castillo-Tong DC, Reinthaller A, Braicu EI, Mahner S, Sehouli J, Vergote I, Theillet C, Zeillinger R, Brandt B. Circulating tumor cells: potential markers of minimal residual disease in ovarian cancer? a study of the OVCAD consortium. Oncotarget. 2017; 8:106415-106428. doi: 10.18632/oncotarget.22468. eCollection 2017. Dec 5.
Hahn S, Trendelenburg G, Scharf M, Denno Y, Brakopp S, Teegen B, Probst C, Wandinger KP, Buttmann M, Haarmann A, Szabados F, vom Dahl M, Kümpfel T, Eichhorn P, Gold HJ, Paul, F, Jarius S, Melzer N, Stöcker W, Komorowsk L: Identification of the flotilin-1/2 heterocomplex as a target of autoantibodies in bona fide multiple sclerosis. J Neuroinflamm 2017; 14: 123.
Ludwig RJ, Vanhoorelbeke K, Leypoldt F, Kaya Z, Bieber K, McLachlan S, Komorowski L, Luo J, Marques O, Hammers CM, Lindstrom JM, Lamprecht P, Fischer A, Riemekasten G, Tersteeg C, Sondermann P, Rapoport B, Wandinger KP, Probst C, El Beidaq A, Schmidt E, Verkman A, Manz RA, Nimmerjahn F. Mechanisms of autoantibody-induced pathology. Front Immunol 2017; 8: 603.
Hennes EM, Baumann M, Schanda K, Anlar B, Bajer-Kornek B, Blaschek A, Brantner-Inthaler S, Diepold K, Eisenkölbl A, Gotwald T, Kuchukhidze G, Gruber-Sedlmayr U, Häusler M, Höftberger R, Karenfort M, Klein A, Koch J, Kraus V, Lechner C, Leiz S, Leypoldt F, Mader S, Marquard K, Poggenburg I, Pohl D, Pritsch M, Raucherzauner M, Schimmel M, Thiels C, Tibussek D, Vieker S, Zeches C, Berger T, Reindl M, Rostásy K, BIOMARKER Study Group: Prognostic relevance of MOG antibodies in children with an acquired demyelinating syndrome. Neurology 2017; 89: 900-8.
Gaig C, Graus F, Compta Y, Högl B, Bataller L, Brüggemann N, Giordana C, Heidbreder A, Kotschet K, Lewerenz J, Macher S, Marti MJ, Montojo T, Perez-Perez J, Puertas , Seitz C, Simabukur M, Tellez N, Wandinger KP, Iranzo A, Ercilla G, Sabater L, Santamaria J, Dalmau J: Clinical manifestations of the anti-IgLON5 disease. Neurology 2017; 88: 1746-3.
Koch M, Furtado JD, Falk K, Leypoldt F, Mukamal KJ, Jensen MK: Apolipoproteins and their subspecies in human cerebrospinal fluid and plasma. Alzheimers Dement (Amst) 2017; 6: 182-7.
Finke C, Prüss H, Heine J, Reuter S, Kopp U, Wegner F, Berg F, Koch S, Jansen O, Münte T, Deuschl G, Ruprecht K, Stöcker W, Wandinger KP, Paul F, Bartsch T: Evaluation of cognitive deficits and structural hippocampal damage in encephalitis with leucine-rich, glioma inactivated 1 antibodies. JAMA Neurol 2017; 74: 50-9.
Rühle F, Witten A, Barysenka A, Huge A, Arning A, Heller C, Krümpel A, Mesters R, Franke A, Lieb W, Riemenschneider M, Hiersche M, Limperger V, Nowak-Göttl U, Stoll M: Rare genetic variants in SMAP1, B3GAT2, and RIMS1 contribute to pediatric venous thromboembolism. Blood 2017; 129: 783-90.
Nicolaus S, Schlulte B, Al-Massad N, Thieme F, Schulte DM, Bethge J, Rehmann A, Tran F, Aden K, Häsler R, Moll N, Schütze G, Schwarz MJ, Waetzig GH, Rosenstiel P, Krawczak M, Syzmchak S, Schreiber S: Increased Tryptophan Metabolism Is Associated With Activity of Inflammatory Bowel Diseases. Gastroenterology 2017; 153: 1504-16.
Vashist S, Luong J, Luppa P, Junker R: Zukünftige POCT-Systeme. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 415-421.
Junker R, Wahl HG: POCT in der Arztpraxis. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 313-317.
Gässler N, Luppa P, Bietenbeck A, Petersmann A, Pröbstl A, Romann D, Junker R: Implementierung von POCT. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 303-312.
Gässler N, Junker R, Langer C, Schäfer B: Ökonomische Aspekte von POCT. In: Luppa P, Junker R, (Hrsg.). POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 295-300.
Kixmüller D, Gässler N, Junker R: Hämatologische Diagnostik. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 159-161.
Luppa P, Junker R, Schimke I, Stürenburg E: Immunologische Verfahren. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 73-83.
Junker R, Gässler N: Klinisch-chemische Parameter. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 67-72.
Kixmüller D, Junker R: Analytik korpuskulärer Blutbestandteile. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 61-65.
Junker R, Petersmann A, Luppa P: Relevanz von POCT im Gesundheitswesen. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 9-17.
Luppa P, Junker R, Langer C: Definitionen und Anwendungsgebiete. In: Luppa P, Junker R, (Hrsg.): POCT – Patientennahe Labordiagnostik. Berlin, Heidelberg, New York: Springer 2017; 3-8.
Leypoldt F, Magnus, T, Voltz R: Paraneoplastische neurologische Syndrome In: Diener, Gerloff, Dieterich: Therapie und Verlauf neurologischer Erkrankungen. Stuttgart: Kohlhammer 2017; 979-989.
Bernard TJ, Poisson S, Branchford BR, Nowak-Göttl U: Coagulation Disorders and Cerebrovascular Disease in Children. In: Swaiman KF, Ashwal S, Ferriero DM, Schor NF, Finkel RS, Gropman AL, Pearl PL , Shevell M: Swaiman's Pediatric Neurology. New York City: Elsiver 2017; 2007-2017.